NeurogesX Company
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Industry:
Genomic and Epigenominc Instabillity
Technology:
Neuromodulation
Funding Status:
N/A
Investment Stage:
N/A
Headquarters:
United States
Employee Number:
11-50
Number Of Exists:
N/A
Investor Type:
N/A
Founded Date:
1998